WJPR Citation New

  All Since 2020
 Citation  8502  4519
 h-index  30  23
 i10-index  227  96

Login

Best Article Awards

World Journal of Pharmaceutical Research (WJPR) is giving Best Article Award in every Issue for Best Article and Issue Certificate of Appreciation to the Authors to promote research activity of scholar.
Best Paper Award :
Dr. Dhrubo Jyoti Sen
Download Article: Click Here

Search

Track Your Article

Abstract

A WELLNESS GUIDE TO AMAVATA

Dr. Vaishnavi Shenoy B.* and Dr. Remi Elizabeth

.

Abstract

Amavata is a disease in which vitiation of Vata Dosha and accumulation of Ama take place in joints, and its symptoms are similar to rheumatoid arthritis (RA) at modern parlance. Amavata which is mentioned in Laghutrayees since the period of Madhavakara (16th century A.D.) under the category of Vata -Kaphaja disorders. Nidanas of Amavata are Viruddhahara, Viruddhachesta, Mandagni, and Vyayama after Snigdhahara. Amavata is one of the chronic, incurable disease and challenging disease for the practioners. The allopathic treatment provides the symptomatic relief but the pathology remains untreated due to absence of effective therapy and also giving rise to many side effects. The Ayurvedic treatment procedure are Langhana, Swedana, Tikta-katu dravya, Deepana, Virechana, Basti. In Ayurveda the prevention is always better than cure. There are various modalities of prevention like Pathya Ahara Vihara, Rasayana, Yoga and Rehabilitation treatment where the patients get better quality of life to live with Amavata. Therefore, a detailed explanation given through holistic way for managing Amavata.

Keywords: Amavata, Rheumatoid Arthritis, Prevention, Pathya Ahara, Vihara.


[Full Text Article]  [Download Certificate]

Call for Paper

World Journal of Pharmaceutical Research (WJPR)
Read More

Email & SMS Alert

World Journal of Pharmaceutical Research (WJPR)
Read More

Article Statistics

World Journal of Pharmaceutical Research (WJPR)
Read More

Online Submission

World Journal of Pharmaceutical Research (WJPR)
Read More